Fund Holdings — Darwin Global Management, Ltd.

Total Portfolio Value:
$1.06B
Total Bought:
$290.66M
Total Sold:
$341.12M
Net Transaction:
-$50.47M
Notable People:
Sarah Elizabeth Monime
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)10,497,27712,960,538+2,463,261$766.30M$894.80M84.75%+$128.49M
Jazz Pharmaceuticals plcSHS USD(JAZZ)0484,515+484,515$0$59.67M5.65%+$59.67M
Verona Pharma PlcADS0810,449+810,449$0$37.64M3.56%+$37.64M
Geron Corporation(GERN)22,038,7739,569,835-12,468,938$100.06M$33.88M3.21%-$66.18M
Keros Therapeutics, Inc.(KROS)1,523,7321,687,135+163,403$88.48M$26.71M2.53%-$61.78M
Nurix Therapeutics, Inc.(NRIX)0163,681+163,681$0$3.08M0.29%+$3.08M
Summit Therapeutics Inc.(SMMT)1,084,8800-1,084,880$23.76M$0—-$23.76M
Vaxcyte, Inc.(PCVX)2,198,1870-2,198,187$251.19M$0—-$251.19M
Page 1 of 1
Darwin Global Management, Ltd. — 13F Holdings — Q4 2024 | TickerTrail